YAP1 and neoplasm: Consistently, it has previously been reported that VP may enhance the effects of gemcitabine and other anti-tumor drugs by inhibiting the expression of YAP1 [46,47,48], by inhibition of autophagy [8] or modulating lysosomal activity [49].